Poly Medicure Limited Stock Net Asset
| POLYMED Stock | 2,582 6.90 0.27% |
Poly Medicure Limited fundamentals help investors to digest information that contributes to Poly Medicure's financial success or failures. It also enables traders to predict the movement of Poly Stock. The fundamental analysis module provides a way to measure Poly Medicure's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Poly Medicure stock.
Poly | Net Asset |
Poly Medicure Limited Company Net Asset Analysis
Poly Medicure's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Poly Medicure Net Asset | 18.59 B |
Most of Poly Medicure's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Poly Medicure Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Poly Total Assets
Total Assets |
|
Based on the recorded statements, Poly Medicure Limited has a Net Asset of 18.59 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net asset for all India stocks is notably lower than that of the firm.
Poly Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Poly Medicure's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Poly Medicure could also be used in its relative valuation, which is a method of valuing Poly Medicure by comparing valuation metrics of similar companies.Poly Medicure is currently under evaluation in net asset category among its peers.
Poly Fundamentals
| Return On Equity | 0.15 | ||||
| Return On Asset | 0.0882 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 250.57 B | ||||
| Shares Outstanding | 101.33 M | ||||
| Shares Owned By Insiders | 67.30 % | ||||
| Shares Owned By Institutions | 16.60 % | ||||
| Price To Book | 10.10 X | ||||
| Price To Sales | 17.19 X | ||||
| Revenue | 13.76 B | ||||
| Gross Profit | 7.06 B | ||||
| EBITDA | 4.2 B | ||||
| Net Income | 2.58 B | ||||
| Cash And Equivalents | 1.76 B | ||||
| Total Debt | 1.74 B | ||||
| Book Value Per Share | 266.96 X | ||||
| Cash Flow From Operations | 2.66 B | ||||
| Earnings Per Share | 30.73 X | ||||
| Target Price | 2475.17 | ||||
| Number Of Employees | 6.3 K | ||||
| Beta | 0.34 | ||||
| Market Capitalization | 261.64 B | ||||
| Total Asset | 18.59 B | ||||
| Retained Earnings | 10.17 B | ||||
| Working Capital | 4.9 B | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 18.59 B |
About Poly Medicure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Poly Medicure Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Poly Medicure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Poly Medicure Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Poly Stock
Poly Medicure financial ratios help investors to determine whether Poly Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Poly with respect to the benefits of owning Poly Medicure security.